Nasopharyngeal Carcinoma Undifferentiated Type
📧 Sign up to get email alerts when something new happens for Nasopharyngeal Carcinoma Undifferentiated Type.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Vorinostat and Azacitidine in Treating Patients With Locally Recurrent or Metastatic Nasopharyngeal Cancer or Nasal Natural Killer T-Cell Lymphoma [Phase 1]
A Phase 1 trial evaluating vorinostat with azacitidine in adults with nasal-type extranodal NK/T-cell lymphoma or recurrent nasopharyngeal c…